本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Syndax Pharmaceuticals, Inc.

14.15
+0.45003.28%
盤前13.92-0.2300-1.63%04:13 EDT
成交量:275.32萬
成交額:3,785.54萬
市值:12.18億
市盈率:-3.80
高:14.24
開:13.36
低:13.14
收:13.70
資料載入中...
2024/03/18

重要事件披露

Form 8-K - Current report
2024/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/20

重要事件披露

Form 8-K - Current report
2023/12/15

重要事件披露

Form 8-K - Current report
2023/12/12

重要事件披露

Form 8-K - Current report
2023/11/29

SEC問詢函

Form CORRESP - Correspondence
2023/11/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/03

重要事件披露

Form 8-K - Current report
2023/11/01

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/06

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/10/02

重要事件披露

Form 8-K - Current report
2023/08/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/03

重要事件披露

Form 8-K - Current report